Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001193125-25-277535
Filing Date
2025-11-12
Accepted
2025-11-12 16:06:43
Documents
19
Effectiveness Date
2025-11-12

Document Format Files

Seq Description Document Type Size
1 S-3ASR d934123ds3asr.htm S-3ASR 306880
2 EX-4.2 d934123dex42.htm EX-4.2 277374
3 EX-4.3 d934123dex43.htm EX-4.3 276953
4 EX-5.1 d934123dex51.htm EX-5.1 15573
5 EX-23.1 d934123dex231.htm EX-23.1 1599
6 EX-FILING FEES d934123dexfilingfees.htm   iXBRL EX-FILING FEES 30655
7 GRAPHIC g934123g02a02.jpg GRAPHIC 17867
8 GRAPHIC g934123g1112000115438.jpg GRAPHIC 2755
9 GRAPHIC g934123g34a01.jpg GRAPHIC 19917
  Complete submission text file 0001193125-25-277535.txt   1106768

Data Files

Seq Description Document Type Size
21 EXTRACTED XBRL INSTANCE DOCUMENT d934123dexfilingfees_htm.xml XML 13166
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

EIN.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-291466 | Film No.: 251472653
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)